BBIO vs IT · rev $221.9M vs P/E 16, rev $6.27B
BridgeBio Pharma Inc (BBIO) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
BBIO currently screens at market cap $13.24B. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the BBIO and IT stock pages for the full models.
Not investment advice.